Checkmate Pharmaceuticals Inc
NASDAQ:CMPI
Cash Flow Statement
Cash Flow Statement
Checkmate Pharmaceuticals Inc
Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow | |||||||||||
Net Income |
(28)
|
(29)
|
(30)
|
(34)
|
(37)
|
(43)
|
(54)
|
(59)
|
(61)
|
(63)
|
|
Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Non-Cash Items |
(0)
|
(0)
|
0
|
1
|
2
|
4
|
5
|
6
|
6
|
6
|
|
Change in Working Capital |
2
|
2
|
2
|
(1)
|
(4)
|
(5)
|
(3)
|
(1)
|
1
|
7
|
|
Cash from Operating Activities |
(27)
N/A
|
(27)
-2%
|
(28)
-3%
|
(34)
-21%
|
(38)
-12%
|
(44)
-16%
|
(52)
-17%
|
(54)
-5%
|
(54)
+1%
|
(50)
+7%
|
|
Investing Cash Flow | |||||||||||
Capital Expenditures |
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(1)
|
(1)
|
0
|
|
Other Items |
0
|
0
|
0
|
0
|
(83)
|
(73)
|
(33)
|
(28)
|
62
|
51
|
|
Cash from Investing Activities |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
(83)
N/A
|
(73)
+12%
|
(34)
+54%
|
(29)
+14%
|
61
N/A
|
50
-18%
|
|
Financing Cash Flow | |||||||||||
Net Issuance of Common Stock |
19
|
16
|
91
|
151
|
150
|
142
|
68
|
(0)
|
0
|
0
|
|
Net Issuance of Debt |
0
|
0
|
10
|
10
|
10
|
0
|
0
|
0
|
0
|
0
|
|
Other |
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
|
Cash from Financing Activities |
19
N/A
|
16
-16%
|
100
+527%
|
161
+60%
|
160
0%
|
152
-5%
|
68
-55%
|
(0)
N/A
|
0
N/A
|
0
N/A
|
|
Change in Cash | |||||||||||
Net Change in Cash |
(8)
N/A
|
(11)
-44%
|
72
N/A
|
127
+76%
|
39
-69%
|
35
-9%
|
(17)
N/A
|
(84)
-388%
|
8
N/A
|
0
-95%
|
|
Free Cash Flow | |||||||||||
Free Cash Flow |
(27)
N/A
|
(27)
-2%
|
(28)
-3%
|
(34)
-21%
|
(38)
-12%
|
(44)
-16%
|
(52)
-18%
|
(55)
-6%
|
(55)
+1%
|
(50)
+8%
|